Search Results

• • 51 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees.

  Authors:Lucas C. Godoy, Michael E. Farkouh, Peter C. Austin, Baiju R. Shah, Feng Qiu, Maneesh Sud, et al.From:American Heart Journal (Vol. 256) Peer-Reviewed

  Feb. 2023416 words Report

   Abstract Only

• The trial to assess chelation therapy 2 (TACT2): Rationale and design.

  Authors:Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas-Acien, Robin Boineau, Hwasoon Kim, Yves Rosenberg, et al.From:American Heart Journal (Vol. 252) Peer-Reviewed

  Oct. 2022583 words Clinical report

   Abstract Only

• Thrombolytic agents: the science of the art of choosing the better treatment

  Authors:Michael E. Farkouh, Jeff D. Lang, and David L. SackettFrom:Annals of Internal Medicine (Vol. 120, Issue 10) Peer-Reviewed

  May 15, 1994128 words Editorial

   Abstract Only

• Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

  Authors:Jeffrey S. Berger, Lucy Z. Kornblith, Michelle N. Gong, Harmony R. Reynolds, Mary Cushman, Yu Cheng, et al.From:JAMA, The Journal of the American Medical Association (Vol. 327, Issue 3) Peer-Reviewed

  Jan. 18, 202263 words Report

   Citation Only

• Clinical risk stratification in the emergency department predicts long-term cardiovascular outcomes in a population-based cohort presenting with acute chest pain: primary results of the Olmsted County Chest Pain Study

  Authors:Michael E. Farkouh, Ashish Aneja, Guy S. Reeder, Peter A. Smars, Sameer Bansilal, Ryan J. Lennon, et al.From:Medicine (Vol. 88, Issue 5) Peer-Reviewed

  Sept. 2009 Clinical report

   Citation Only

• Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V

  Authors:Harmony R. Reynolds, Michael E. Farkouh, A. Michael Lincoff, Eva Swahn, Zygmunt P. Sadowski, Jennifer A. White, et al.From:Archives of Internal Medicine (Vol. 167, Issue 19) Peer-Reviewed

  Oct. 22, 2007 Clinical report

   Citation Only

• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

  Authors:Patrick R. Lawler, Ewan C. Goligher, Jeffrey S. Berger, Matthew D. Neal, Bryan J. McVerry, Jose C. Nicolau, et al.From:The New England Journal of Medicine (Vol. 385, Issue 9) Peer-Reviewed

  Aug. 26, 202140 words Report

   Citation Only

• Appropriate Cardiac Cath Lab activation: Optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction

  Authors:Ivan C. Rokos, William J. French, Amal Mattu, Graham Nichol, Michael E. Farkouh, James Reiffel, et al.From:American Heart Journal (Vol. 160, Issue 6) Peer-Reviewed

  Dec. 2010237 words Article

   Abstract Only

• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

  Authors:Michael E. Farkouh, Howard Kirshner, Robert A. Harrington, Sean Ruland, Freek W.A. Verheugt, Thomas J. Schnitzer, et al.From:The Lancet (Vol. 364, Issue 9435) Peer-Reviewed

  Aug. 21, 2004331 words Article

   Abstract Only

• Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery

  Authors:Louai Razzouk, Frederick Feit, and Michael E. FarkouhFrom:Current Cardiology Reports (Vol. 19, Issue 5)

  May 2017332 words Report

   Abstract Only

• Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry.

  Authors:Naveen L. Pereira, Robert Avram, Derek Y. So, Erin Iturriaga, Julia Byrne, Ryan J. Lennon, et al.From:American Heart Journal (Vol. 232) Peer-Reviewed

  Feb. 2021596 words Clinical report

   Abstract Only

• Non-steroidal anti-inflammatory drugs and the heart

  Authors:Ashish Aneja and Michael E. FarkouhFrom:Heart (Vol. 97, Issue 7) Peer-Reviewed

  Apr. 1, 2011 Editorial

   Citation Only

• Strategies for multilevel revascularization in patients with diabetes

  Authors:Michael E. Farkouh, Michael Domanski, Lynn A. Sleeper, Flora S. Siami, George Dangas, Michael Mack, et al.From:The New England Journal of Medicine (Vol. 367, Issue 25) Peer-Reviewed

  Dec. 20, 201250 words Clinical report

   Citation Only

• Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes.

  Authors:Rebecca Crosier, Peter C. Austin, Dennis T. Ko, Patrick R. Lawler, Therese A. Stukel, Michael E. Farkouh, et al.From:American Journal of Medicine (Vol. 134, Issue 5) Peer-Reviewed

  May 2021619 words Report

   Abstract Only

• Lumiracoxib, a highly selective COX-2 inhibitor

  Authors:Raban V Jeger, Jeffrey D Greenberg, Krishnan Ramanathan, and Michael E FarkouhFrom:Expert Review of Clinical Immunology (Vol. 1, Issue 1) Peer-Reviewed

  May 20058,124 words Article Author(s): Raban V Jeger 1 , Jeffrey D Greenberg 2 , Krishnan Ramanathan 3 , Michael E Farkouh [[dagger]] 4 Keywords: adverse effects; cyclooxygenase 2; myocardial infarction; nonsteroidal anti-inflammatory...

• The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design

  Authors:Kristina Lambrakis, John K. French, Ian A. Scott, Tom Briffa, David Brieger, Michael E. Farkouh, et al.From:American Heart Journal (Vol. 208) Peer-Reviewed

  Feb. 2019523 words Clinical report

   Abstract Only

• Awareness, treatment, and control of LDL cholesterol are lower among u.s. adults with undiagnosed diabetes versus diagnosed diabetes

  Authors:Todd M. Brown, Rikki M. Tanner, April P. Carson, Huifeng Yun, Robert S. Rosenson, Michael E. Farkouh, et al.From:Diabetes Care (Vol. 36, Issue 9) Peer-Reviewed

  Sept. 20134,588 words Article 1530LOBJECTIVE--Diabetes is often undiagnosed, resulting in incorrect risk stratification for lipid-lowering therapy. We conducted a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES)...

• Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes

  Authors:Rajendra H. Mehta, Sarah Milford-Beland, Eric D. Peterson, Deepak L. Bhatt, Michael E. Farkouh, Gerald X. Brogan, et al.From:Diabetes Care (Vol. 30, Issue 3) Peer-Reviewed

  Mar. 20071,771 words Clinical report 1650LMost information regarding the prognosis and quality of care of patients with diabetes and acute coronary syndromes (ACSs) is derived from studies that have largely focused on middle-aged and older populations (1-3)....

• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.

  Authors:Ewan C. Goligher, Charlotte A. Bradbury, Bryan J. McVerry, Patrick R. Lawler, Jeffrey S. Berger, Michelle N. Gong, et al.From:The New England Journal of Medicine (Vol. 385, Issue 9) Peer-Reviewed

  Aug. 26, 202146 words Report

   Citation Only

• Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: A systematic review and meta-analysis of randomized clinical trials

  Authors:Ole Kohler, Michael E. Benros, Merete Nordentoft, Michael E. Farkouh, Rupa L. Iyengar, Ole Mors, et al.From:JAMA Psychiatry (Vol. 71, Issue 12) Peer-Reviewed

  Dec. 2014 Report

   Citation Only